SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is trending as traders closely monitor the government shutdown vote, anticipating market impacts. Community discussions revolve around whether the reopening is already priced in, while some express concern over potentially delayed economic data. There's also chatter about the possible release of Epstein files and how that may impact the markets.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as traders react to the House passing a bill to end the government shutdown and anticipate Trump's signature. While some community members are optimistic about a potential rally, others believe the news is already priced in and are watching for a "sell the news" event or a sector rotation. There is also a lot of talk about a possible AI bubble and the potential impact of delayed economic data.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amid discussions surrounding newly released Epstein emails and Trump's alleged connections, sparking renewed scrutiny and debate. Community members are actively discussing the implications of these revelations, with some questioning Trump's past associations and others defending him against the allegations. The stock's performance is being closely watched in light of these developments.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JASMY is trending amidst mixed sentiment regarding its future and the impact of the recently launched Janction (JCT) token; some community members express concerns about resource allocation between the two projects, while others view JCT as beneficial to the broader Jasmy ecosystem and driving demand. Discussions also include technical analysis, price predictions, and frustration with the token's performance in a fluctuating market.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending downwards as investors discuss an upcoming lockup expiration, potentially leading to increased selling pressure. Despite some bullish sentiment and Cathie Wood's ARK Invest adding shares, the community is wary of potential insider selling. Discussions also involve the broader stablecoin market and regulatory landscape, with some comparing CRCL to other hyped IPOs.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending due to activist investor Shah Capital pushing for the company's sale, citing management's "profound lack of competence" and expressing frustration over Novavax's minuscule COVID vaccine market share. The community is echoing Shah's concerns, criticizing CEO John Jacobs' leadership and advocating for a sale to a larger pharmaceutical company. Discussions center on whether a sale is the best path forward, given the company's struggles in the competitive vaccine market.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as investors discuss the company's upcoming presentation at the Inflammatory Skin Disease Summit and a confirmed FDA meeting in December, both seen as potential catalysts. Bullish sentiment is fueled by significant institutional ownership and recent data suggesting a best-in-class profile for their drug, SLK, despite a recent public offering.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is trending as community members discuss its potential as the next Palantir, fueled by a recent acquisition and Q3 earnings. Bullish sentiment is further driven by the anticipation of government contracts, particularly related to border security, following the potential government reopening. Discussions also focus on high short interest and potential for a short squeeze.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor ($OPEN) is trending due to a potential short squeeze, fueled by an upcoming warrant distribution and the CEO's recent stock purchase, signaling strong confidence. The community is actively discussing the possibility of a significant squeeze, drawing comparisons to other high-profile situations and highlighting the warrant issuance as a key catalyst for short covering. Amidst this, some traders have pointed to potentially dilutive effects to the stock price.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney ($DIS) is trending due to upcoming earnings, with community members actively discussing potential catalysts and market sentiment. Bullish sentiment is fueled by the possibility of a solid earnings beat and positive momentum, while others express concerns about various challenges and the stock's historical performance. Discussions also include Disney's streaming strategy, theme park performance, and broader market context, as well as some chatter about a dispute with Youtube TV.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Bausch Health Companies (TSE:BHC) Stock Price Up 6.3% - Here's What Happened

Bausch Health Companies (TSE:BHC) Shares Up 6.3% - Here's Why...

Will Bausch (BHC) Gain on Rising Earnings Estimates?

Bausch Health (BHC) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

BHC Stock Up on Q3 Earnings Beat, Salix and Solta Drive Sales 

Bausch Health's Q3 results top expectations as strong Salix and Solta sales fuel growth. Shares gain.

Bausch Health (BHC) Expected to Beat Earnings Estimates: Should You Buy?

Bausch (BHC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bausch (BHC) Up 21.4% Since Last Earnings Report: Can It Continue?

Bausch (BHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat

BHC stock falls 6.3% as Q2 earnings miss estimates despite stronger sales and growth in key segments like Salix and Solta Medical.

Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Bausch (BHC) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Bausch Health (BHC) Lags Q2 Earnings Estimates

Bausch (BHC) delivered earnings and revenue surprises of -7.22% and +2.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Up 110%+, our AI-powered stock picks for July are out: See them now

Likewise, our global portfolios are also beating their respective benchmark indexes by a wide margin. See below:

This giant is up 15%+ today on earnings and our AI model already knew

At the start of each month, our AI refreshes each strategy with up to 20 stock picks. These selections are based on a blend of more than 150 well-established financial models compiled by our machine learning model on over 15 years of financial data worldwide.

Bausch Health Cos., Inc. engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: Salix, International, Solta Medical, Diversified Products, and Bausch + Lomb. The Salix segment consists of sales in the U.S. of GI products. Sales of the Xifaxan product line. The International segment comprises of sales, except for sales of Bausch + Lomb products and Solta aesthetic medical devices, outside the U.S and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical and OTC products. The Solta Medical segment refers to global sales of Solta Medical aesthetic medical devices. The Diversified Products segment covers sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, generic products, ortho dermatologic, and dentistry products. The Bausch + Lomb segment are global sales of Bausch + Lomb vision care, surgical and ophthalmic pharmaceuticals products. The company was founded on March 29, 1994, and is headquartered in Laval, Canada.

Bausch Health Companies Inc

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$6.94
Prev Close	$6.81
Open	$6.84
Dividend Yield	0.00%
50-Day Moving Average	$6.60
Beta	1.20
Avg. Volume	1.94M
PE Ratio	7.16

52-Week High	$8.87
52-Week Low	$4.25
Market Capitalization	$2.57B
EPS (Annual)	-$0.125
Price to Book	-4.55
Revenue Per Employee	$464,975.84
Enterprise Value/EBITDA	N/A

BHC
Bausch Health Companies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BHC News

BHCBausch Health Companies Inc